Analysts Raise PACS Group Price Targets After Q3 Earnings
Truist raised its target to $65 from $62, Stephens & Co. to $64 from $60, and UBS to $67 from $60. All maintained their existing ratings.
Following PACS Group's third-quarter 2026 earnings release, several analysts adjusted their outlooks for the company. Truist raised its price target to $65 from $62 while maintaining a Buy rating. Stephens & Co. maintained an Overweight rating and increased its price target to $64 from $60.
Additionally, UBS raised its price target to $67 from $60 and maintained a Buy rating. These adjustments reflect analyst reactions to the company's recent financial performance and updated guidance.